Bluestar Adisseo Past Earnings Performance
Past criteria checks 4/6
Bluestar Adisseo's earnings have been declining at an average annual rate of -15.7%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 5.3% per year. Bluestar Adisseo's return on equity is 4.1%, and it has net margins of 4.4%.
Key information
-15.7%
Earnings growth rate
-15.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 5.3% |
| Return on equity | 4.1% |
| Net Margin | 4.4% |
| Next Earnings Update | 30 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bluestar Adisseo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 14,116 | 626 | 2,144 | 419 |
| 31 Mar 24 | 13,527 | 328 | 2,153 | 404 |
| 31 Dec 23 | 13,184 | 52 | 2,037 | 411 |
| 30 Sep 23 | 13,343 | 69 | 1,984 | 398 |
| 30 Jun 23 | 13,662 | 411 | 1,949 | 389 |
| 31 Mar 23 | 14,224 | 821 | 1,902 | 383 |
| 31 Dec 22 | 14,529 | 1,247 | 1,869 | 352 |
| 30 Sep 22 | 14,326 | 1,365 | 1,586 | 359 |
| 30 Jun 22 | 14,085 | 1,525 | 1,688 | 349 |
| 31 Mar 22 | 13,333 | 1,532 | 1,782 | 330 |
| 31 Dec 21 | 12,869 | 1,472 | 1,847 | 338 |
| 30 Sep 21 | 12,372 | 1,504 | 2,104 | 326 |
| 30 Jun 21 | 12,003 | 1,449 | 2,034 | 310 |
| 31 Mar 21 | 12,052 | 1,424 | 1,987 | 304 |
| 31 Dec 20 | 11,910 | 1,352 | 1,963 | 292 |
| 30 Sep 20 | 11,704 | 1,279 | 1,962 | 273 |
| 30 Jun 20 | 11,664 | 1,178 | 1,983 | 302 |
| 31 Mar 20 | 11,255 | 991 | 1,953 | 278 |
| 31 Dec 19 | 11,135 | 992 | 1,910 | 290 |
| 30 Sep 19 | 11,205 | 1,028 | 1,960 | 314 |
| 30 Jun 19 | 11,025 | 971 | 1,926 | 274 |
| 31 Mar 19 | 11,137 | 870 | 1,853 | 293 |
| 31 Dec 18 | 11,418 | 926 | 1,893 | 285 |
| 30 Sep 18 | 11,306 | 1,121 | 1,721 | 273 |
| 30 Jun 18 | 11,216 | 1,235 | 1,543 | 365 |
| 31 Mar 18 | 10,943 | 1,359 | 1,577 | 300 |
| 31 Dec 17 | 10,398 | 1,323 | 1,489 | 232 |
| 30 Sep 17 | 10,216 | 1,232 | 1,701 | 149 |
| 30 Jun 17 | 10,185 | 1,341 | 1,839 | 0 |
| 31 Mar 17 | 10,410 | 1,621 | 1,785 | 0 |
| 31 Dec 16 | 10,688 | 1,865 | 1,751 | 0 |
| 30 Sep 16 | 11,036 | 1,848 | 1,737 | 0 |
| 30 Jun 16 | 11,658 | 2,103 | 1,648 | 0 |
| 31 Mar 16 | 13,365 | 1,605 | 1,829 | 0 |
| 31 Dec 15 | 15,173 | 1,529 | 1,972 | 0 |
| 30 Sep 15 | 17,189 | 2,675 | 2,050 | 0 |
| 30 Jun 15 | 19,078 | 2,155 | 2,291 | 0 |
| 31 Mar 15 | 21,838 | 1,716 | 2,557 | 0 |
| 31 Dec 14 | 19,465 | 1,475 | 2,353 | 0 |
| 31 Dec 13 | 8,532 | 1,063 | 1,185 | 0 |
Quality Earnings: 600299 has high quality earnings.
Growing Profit Margin: 600299's current net profit margins (4.4%) are higher than last year (3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600299's earnings have declined by 15.7% per year over the past 5 years.
Accelerating Growth: 600299's earnings growth over the past year (52.5%) exceeds its 5-year average (-15.7% per year).
Earnings vs Industry: 600299 earnings growth over the past year (52.5%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 600299's Return on Equity (4.1%) is considered low.